inactivated split-virion influenza vaccine with adjuvant

This page covers all inactivated split-virion influenza vaccine with adjuvant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

• H5N1 vaccine (Arepanrix) · Canadian Immunization Research Network · Immunology
  Arepanrix is an inactivated split-virion H5N1 influenza vaccine that stimulates the immune system to produce antibodies against the H5N1 avian influenza virus.

Patent intelligence

• inactivated split virion influenza vaccine with adjuvant patent landscape — aggregated cliff calendar, attackable patents, originator estates